UF Health Cancer Center at Orlando Health
Welcome,         Profile    Billing    Logout  
 10 Trials 
24 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Kayaleh, Omar R
COBRA, NCT04068103: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Active, not recruiting
2/3
1408
Canada, US
Capecitabine, Ro 09-1978/000, Xeloda, Fluorouracil, 5-Fluoro-2,4(1H, 3H)-pyrimidinedione, 5-Fluorouracil, 5-Fluracil, 5-FU, AccuSite, Carac, Fluoro Uracil, Fluouracil, Flurablastin, Fluracedyl, Fluracil, Fluril, Fluroblastin, Ribofluor, Ro 2-9757, Ro-2-9757, Leucovorin, Folinic acid, Leucovorin Calcium, Adinepar, Calcifolin, Calcium (6S)-Folinate, Calcium Folinate, Calcium Leucovorin, Calfolex, Calinat, Cehafolin, Citofolin, Citrec, citrovorum factor, Cromatonbic Folinico, Dalisol, Disintox, Divical, Ecofol, Emovis, Factor, Citrovorum, Flynoken A, Folaren, Folaxin, FOLI-cell, Foliben, Folidan, Folidar, Folinac, Folinate Calcium, folinic acid, Folinic Acid Calcium Salt Pentahydrate, Folinoral, Folinvit, Foliplus, Folix, Imo, Lederfolat, Lederfolin, Leucosar, leucovorin, Rescufolin, Rescuvolin, Tonofolin, Wellcovorin, Oxaliplatin, 1-OHP, Ai Heng, Aiheng, Dacotin, Dacplat, Diaminocyclohexane Oxalatoplatinum, Eloxatin, Eloxatine, JM-83, Oxalatoplatin, Oxalatoplatinum, RP 54780, RP-54780, SR-96669, Patient Observation, Active Surveillance, deferred therapy, expectant management, observation, Watchful Waiting
NRG Oncology, National Cancer Institute (NCI)
Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8
06/23
04/27
GRANITE, NCT05141721: A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

Active, not recruiting
2/3
700
US
GRT-C901, GRT-R902, Atezolizumab, Tecentriq, Ipilimumab, Yervoy, Fluoropyrimidine plus leucovorin, Xeloda, Bevacizumab, Avastin
Gritstone bio, Inc.
Colorectal Neoplasms
03/27
03/27
CIRCULATE-US, NCT05174169: Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Recruiting
2/3
1912
Canada, US
Signatera test, mFOLFOX6 3-6 month, CAPOX 3 month, mFOLFIRINOX, mFOLFOX6 6 month, CAPOX 6 month
NRG Oncology, Natera, Inc., National Cancer Institute (NCI)
Stage III Colon Cancer
03/29
03/30
NEO-Nal- IRI, NCT03483038: A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma

Active, not recruiting
2
45
US
Liposomal Irinotecan, ONIVYDE, FOLFOX regimen
University of Florida, Ipsen
Pancreatic Adenocarcinoma
09/23
07/25
KISIMA-02, NCT05846516: A Study to Evaluate ATP150/ATP152, VSV-GP154 and Ezabenlimab in Patients With KRAS G12D/G12V Mutated PDAC

Recruiting
1
85
Europe, US
VSV-GP154, ATP150, ATP152, Ezabenlimab
Amal Therapeutics, Boehringer Ingelheim
Pancreatic Ductal Adenocarcinoma
12/26
03/27
Avgeropoulos, Nicholas G
ATTAC II, NCT02465268: Vaccine Therapy for the Treatment of Newly Diagnosed Glioblastoma Multiforme

Completed
2
175
US
pp65-shLAMP DC with GM-CSF, pp65-shLAMP mRNA DCs with GM-CSF, unpulsed PBMC and saline, Peripheral Blood Mononuclear Cells, Td, Tetanus and Diphtheria Toxoid, Saline, Normal Saline, pp65-flLAMP DC with GM-CSF, pp65-flLAMP mRNA DCs with GM-CSF
University of Florida, National Cancer Institute (NCI)
Glioblastoma Multiforme, Glioblastoma, Malignant Glioma, Astrocytoma, Grade IV, GBM
11/23
11/23
NCT03173950: Immune Checkpoint Inhibitor Nivolumab in People With Recurrent Select Rare CNS Cancers

Active, not recruiting
2
108
US
Nivolumab
National Cancer Institute (NCI)
Medulloblastoma, Ependymoma, Pineal Region Tumors, Choroid Plexus Tumors, Atypical/Malignant Meningioma
07/25
07/26
TRIDENT, NCT04471844: Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant with RT & TMZ for the Treatment of Newly Diagnosed GBM

Active, not recruiting
N/A
982
Europe, Canada, Japan, US, RoW
Optune®
NovoCure Ltd.
Glioblastoma Multiforme
01/26
01/26
Ramakrishna, Naren
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC).

Completed
3
298
Europe, Canada, US, RoW
NovoTTF-200M device, Best Standard of Care
NovoCure GmbH
Brain Metastases from Non-small Cell Lung Cancer (NSCLC)
11/24
11/24
NCT02040467: Registry for Proton Beam Radiation Therapy

Completed
N/A
1243
US
Washington University School of Medicine
Carcinoma
06/23
06/23
PCG 001-09, NCT01255748: Registry Study for Radiation Therapy Outcomes

Recruiting
N/A
40000
US
Proton Therapy, Photon Therapy, SRS, Brachytherapy
Proton Collaborative Group
Neoplasms
06/39
 
Morales, Leticia
NCT05954767: IS-001 Injection in Patients Undergoing Robotic-Assisted Gynecological Surgery

Recruiting
3
237
US
IS-001
Intuitive Surgical
Ureter Injury
05/25
07/25
NCT04411823: Post-sleeve Gastrectomy Gastroesophageal Reflux Disease Prediction

Recruiting
N/A
200
US
EndoFLIP measurement
Mayo Clinic
Gastroesophageal Reflux, Sleeve Gastrectomy, Bariatric Surgery Complication
10/28
10/28
FLOWS, NCT06454916: Functional Lumen Opening With Self-Forming Magnetic Anastomosis

Recruiting
N/A
70
US
Small Bowel Anastomosis with Flexagon SFM Device with OTOLoc
GI Windows, Inc.
Small Bowel Anastomosis
06/25
08/25
Pelley, Jennifer
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial

Recruiting
N/A
1247
Europe, Canada, US
Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System
Edwards Lifesciences
Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation
01/25
04/30
ECLIPSE, NCT03108456: Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The Trial

Active, not recruiting
N/A
2005
US
Orbital Atherectomy, Balloon
Abbott Medical Devices, Cardiovascular Research Foundation, New York
Coronary Artery Disease, Ischemic Heart Disease, Non ST Segment Elevation Myocardial Infarction
06/24
06/25
NCT04600791: BATwire Implant Kit

Active, not recruiting
N/A
93
US
BATwire Implant Kit
CVRx, Inc.
Heart Failure
08/24
07/25
PERFORMANCEIII, NCT05845710: Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Recruiting
N/A
229
US
Neuroguard IEP Direct System
Contego Medical, Inc., Yale Cardiovascular Research Group, CardioMed Device Consultants, LLC, Advance Research Associates, iMedNet, AG Mednet
Carotid Stenosis, Carotid Artery Diseases
06/25
07/25
INTERRUPT AF, NCT03729830: Prospective Evaluation of Open Irrigated Ablation Catheters With High Resolution Mapping to Treat Paroxysmal Atrial Fibrillation

Completed
N/A
415
Europe, Japan, US, RoW
Boston Scientific Open Irrigated Ablation Catheters
Boston Scientific Corporation
Paroxysmal Atrial Fibrillation
05/24
05/24
LeAAPS, NCT05478304: Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Recruiting
N/A
6500
Europe, Canada, US
AtriClip LAA Exclusion System
AtriCure, Inc., Population Health Research Institute
Ischemic Stroke, Systemic Embolism
12/31
04/32
Jones, Erica
REACT-AF, NCT05836987: The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

Recruiting
3
5350
US
AFSW Guided DOAC, Apple Watch, Continuous DOAC therapy, Oral Anticoagulation therapy
Johns Hopkins University, National Heart, Lung, and Blood Institute (NHLBI)
Atrial Fibrillation
07/29
07/29
VERBATIM, NCT06253780: Multidisciplinary Study to Verify Blood Pressure Documentation and Response to Titration of Intravenous Medications

Recruiting
N/A
30
US
University of Texas Southwestern Medical Center, Chiesi USA, Inc.
Blood Pressure
12/24
12/25
NCT04798378: NuroSleeve Powered Brace & Stimulation System to Restore Arm Function

Recruiting
N/A
20
US
Neurosleeve
Thomas Jefferson University
Neurologic Diseases, Hemiparesis, Quadriplegia, Muscular Dystrophies, Arthrogryposis, Spinal Cord Injuries, Charcot-Marie-Tooth, Stroke, Weakness of Extremities as Sequela of Stroke, Weakness Due to Upper Motor Neuron Dysfunction, Amyotrophic Lateral Sclerosis, Spinal Muscular Atrophy, Arm Paralysis, Cerebral Palsy
12/25
12/25
RISES-T, NCT05669508: Wearable Electrical Stimulation on the Back to Modulate Spinal Cord Activity

Active, not recruiting
N/A
4
US
RISES-T System, Transcutaneous spinal stimulation, Occupational/Physical Therapy, Functional Task Practice
Thomas Jefferson University, Kessler Foundation
Spinal Cord Injuries, Spinal Cord Diseases
12/25
12/26

Download Options